Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges

作者: Clarissa Gerhauser

DOI: 10.1007/128_2012_360

关键词:

摘要: The term “epigenetics” refers to modifications in gene expression caused by heritable, but potentially reversible, changes DNA methylation and chromatin structure. Epigenetic alterations have been identified as promising new targets for cancer prevention strategies they occur early during carcinogenesis represent initiating events development. Over the past few years, nutri-epigenetics – influence of dietary components on mechanisms influencing epigenome has emerged an exciting field current epigenetic research. During carcinogenesis, major cellular functions pathways, including drug metabolism, cell cycle regulation, potential repair damage or induce apoptosis, response inflammatory stimuli, signalling, growth control differentiation become deregulated. Recent evidence now indicates that contribute these defects, example silencing detoxifying enzymes, tumor suppressor genes, regulators, apoptosis-inducing nuclear receptors, signal transducers transcription factors promoter methylation, histones non-histone proteins such p53, NF-κB, chaperone HSP90 acetylation methylation.

参考文章(286)
Aldo Giudice, Claudio Arra, Maria C. Turco, Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods of Molecular Biology. ,vol. 647, pp. 37- 74 ,(2010) , 10.1007/978-1-60761-738-9_3
Mohammad Raish, Varinderpal S. Dhillon, Arif Ahmad, Mushtaq Ahmad Ansari, Shahid Mudassar, Mohammad Shahid, Vineeta Batra, Pawan Gupta, Bhudev Chandra Das, N.K. Shukla, Syed Akhtar Husain, Promoter Hypermethylation in Tumor Suppressing Genes p16 and FHIT and Their Relationship with Estrogen Receptor and Progesterone Receptor Status in Breast Cancer Patients from Northern India Translational Oncology. ,vol. 2, pp. 264- 270 ,(2009) , 10.1593/TLO.09148
Nutrients and Epigenetics CRC Press. pp. 1- 250 ,(2009) , 10.1201/9781420063561
Jia Chen, Xinran Xu, Diet, epigenetic, and cancer prevention. Advances in Genetics. ,vol. 71, pp. 237- 255 ,(2010) , 10.1016/B978-0-12-380864-6.00008-0
Dammann R, Strunnikova M, Pfeifer Gp, Rastetter M, Seidel C, Schagdarsurengin U, Baier K, The tumor suppressor RASSF1A in human carcinogenesis: an update. Histology and Histopathology. ,vol. 20, pp. 645- 663 ,(2005) , 10.14670/HH-20.645
Jeung-Whan Han, Hoi Young Lee, Seung Hee Park, Dong-Wan Seo, Sungyoul Hong, Hyoung-Keun Kwon, Yin-Won Lee, Hyang-Woo Lee, So Young Wang, Gyu-Un Bae, Seong Hoon Ahn, Apicidin, a Histone Deacetylase Inhibitor, Inhibits Proliferation of Tumor Cells via Induction of p21WAF1/Cip1 and Gelsolin Cancer Research. ,vol. 60, pp. 6068- 6074 ,(2000)
Jing-Yuan Fang, Effects of histone acetylation and DNA methylation on p21WAF1regulation World Journal of Gastroenterology. ,vol. 8, pp. 400- 405 ,(2002) , 10.3748/WJG.V8.I3.400
Anup K. Upadhyay, Xiaodong Cheng, Dynamics of Histone Lysine Methylation: Structures of Methyl Writers and Erasers Epigenetics and Disease. ,vol. 67, pp. 107- 124 ,(2011) , 10.1007/978-3-7643-8989-5_6
Manel Esteller, Manel Esteller, Stephen B. Baylin, James G. Herman, Paul G. Corn, A Gene Hypermethylation Profile of Human Cancer Cancer Research. ,vol. 61, pp. 3225- 3229 ,(2001)
Alison M. Michie, Alison M. McCaig, Rinako Nakagawa, Milica Vukovic, Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer. FEBS Journal. ,vol. 277, pp. 74- 80 ,(2010) , 10.1111/J.1742-4658.2009.07414.X